I am originally from Montreal, Canada, where I have spent most of my life. In my young years as a student, I initially intended for a social science career and studied Histoire et Civilisation in CÉGEP. Realizing that my favorite classes were the optional math courses, I reoriented myself very quickly. I obtained my undergraduate degree in Mathematics and Statistics at Université de Montréal in 2013. During those years, I was involved in the Mathematics and Statistics Student Association. I also did a one-year student exchange program at the Université Montpellier II in Montpellier, France. I had amazing mentors during my undergraduate years who made me discover the subtleties of probabilities and statistics: Drs. David Haziza, Pierre LaFaye de Micheaux, Alexandro Murua, Xavier Bry, to name only those.
I looked for opportunities for pursuing my studies in Statistics or any related field. I wanted to do something good for the universe with the time and energy I would spend studying. Biostatistics appeared as an evidence: I could help the big machinery of medical research, maybe find a cure for HIV and hopefully save lives with my R code. I completed my Master degree in Biostatistics at McGill University in 2015, under the direction of Dr. Andrea Benedetti. During those two years, I learned a lot from my colleagues, advisors and mentors, but also from the many consulting projects I have collaborated to. I see my Master as a transition phase, going from student to expert, from “I don’t like to go to class” to “what a privilege to sit down with a coffee and have an expert sharing his thoughts on his topic of expertise.”
I am currently a Biostatistics PhD candidate at McGill University. I work under the supervision of Drs. Erica Moodie and Robert Platt, who act not only as directors for my research but also as resourceful mentors. Beside the hard work I put on my doctoral research, I actively participate in / volunteer for / organize events for the students in Biostatistics and work on several consulting projects, mostly for the Montreal Neurological Institute. I also worked on a project for Biogen, an American pharmaceutical company specialized in the development of treatments for neurological diseases.